Biogen Shares Outstanding 2006-2018 | BIIB

Biogen shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Biogen shares outstanding for the quarter ending December 31, 2018 were 0.205B, a 3.62% decline year-over-year.
Biogen 2018 shares outstanding were 0.205B, a 3.62% decline from 2017.
Biogen 2017 shares outstanding were 0.213B, a 2.65% decline from 2016.
Biogen 2016 shares outstanding were 0.219B, a 5.36% decline from 2015.

Biogen Annual Shares Outstanding (Millions of Shares)
2018	205
2017	213
2016	219
2015	231
2014	237
2013	238
2012	240
2011	245
2010	255
2009	289
2008	295
2007	320
2006	345
2005	346

Biogen Quarterly Shares Outstanding (Millions of Shares)
Q4 2018	205
Q3 2018	202
Q2 2018	207
Q1 2018	212
Q4 2017	213
Q3 2017	212
Q2 2017	212
Q1 2017	216
Q4 2016	219
Q3 2016	219
Q2 2016	219
Q1 2016	219
Q4 2015	231
Q3 2015	233
Q2 2015	236
Q1 2015	236
Q4 2014	237
Q3 2014	237
Q2 2014	237
Q1 2014	238
Q4 2013	238
Q3 2013	238
Q2 2013	239
Q1 2013	238
Q4 2012	240
Q3 2012	238
Q2 2012	241
Q1 2012	242
Q4 2011	245
Q3 2011	245
Q2 2011	245
Q1 2011	245
Q4 2010	255
Q3 2010	242
Q2 2010	262
Q1 2010	273
Q4 2009	289
Q3 2009	291
Q2 2009	290
Q1 2009	290
Q4 2008	295
Q3 2008	294
Q2 2008	293
Q1 2008	300
Q4 2007	320
Q3 2007	293
Q2 2007	343
Q1 2007	344
Q4 2006	345
Q3 2006	345
Q2 2006	342
Q1 2006	346
Q4 2005	346
Q3 2005	341
Q2 2005	345
Q1 2005	352

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$45.009B	$13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$108.629B	12.24
Gilead Sciences (GILD)	United States	$78.878B	10.04
Celgene (CELG)	United States	$65.623B	12.13
Illumina (ILMN)	United States	$46.877B	55.78
Vertex Pharmaceuticals (VRTX)	United States	$43.083B	57.71
Regeneron Pharmaceuticals (REGN)	United States	$36.501B	16.96
Alexion Pharmaceuticals (ALXN)	United States	$28.819B	17.86
Incyte (INCY)	United States	$15.783B	147.32
BioMarin Pharmaceutical (BMRN)	United States	$14.932B	0.00
Exact Sciences (EXAS)	United States	$11.403B	0.00
Seattle Genetics (SGEN)	United States	$11.067B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$9.133B	52.39
Alnylam Pharmaceuticals (ALNY)	United States	$8.840B	0.00
QIAGEN (QGEN)	Netherlands	$8.567B	28.35
Sarepta Therapeutics (SRPT)	United States	$8.112B	0.00
Moderna (MRNA)	United States	$7.774B	0.00
Bluebird Bio (BLUE)	United States	$7.447B	0.00
Bio-Techne Corp (TECH)	United States	$7.219B	48.64
BeiGene (BGNE)	Cayman Islands	$7.182B	0.00
Exelixis (EXEL)	United States	$6.211B	14.41
Amarin (AMRN)	Ireland	$5.861B	0.00
Galapagos (GLPG)	Belgium	$5.857B	0.00
Guardant Health (GH)	United States	$5.494B	0.00
Alkermes (ALKS)	Ireland	$5.282B	0.00
Array BioPharma (ARRY)	United States	$4.871B	0.00
Ascendis Pharma (ASND)	Denmark	$4.598B	0.00
Horizon Pharma Public (HZNP)	Ireland	$4.524B	13.40
Spark Therapeutics (ONCE)	United States	$4.199B	0.00
China Biologic Products (CBPO)	China	$3.863B	23.93
ARGENX SE-ADR (ARGX)	Netherlands	$3.814B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$3.416B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$3.352B	0.00
Blueprint Medicines (BPMC)	United States	$3.326B	0.00
Immunomedics (IMMU)	United States	$3.171B	0.00
Allogene Therapeutics (ALLO)	United States	$3.133B	0.00
Global Blood Therapeutics (GBT)	United States	$3.040B	0.00
MorphoSys AG Unsponsored ADR (MOR)	Germany	$3.022B	0.00
Amicus Therapeutics (FOLD)	United States	$2.839B	0.00
Biohaven Pharmaceutical Holding (BHVN)	United States	$2.696B	0.00
Emergent Biosolutions (EBS)	United States	$2.684B	22.32
Intercept Pharmaceuticals (ICPT)	United States	$2.584B	0.00
Ligand Pharmaceuticals (LGND)	United States	$2.573B	19.21
Repligen (RGEN)	United States	$2.413B	73.97
Akcea Therapeutics (AKCA)	United States	$2.412B	0.00
Denali Therapeutics (DNLI)	United States	$2.371B	0.00
Insmed (INSM)	United States	$2.369B	0.00
Genomic Health (GHDX)	United States	$2.343B	59.89
Myriad Genetics (MYGN)	United States	$2.339B	23.82
Halozyme Therapeutics (HALO)	United States	$2.338B	0.00
Reata Pharmaceuticals (RETA)	United States	$2.314B	0.00
Mirati Therapeutics (MRTX)	United States	$2.233B	0.00
Arena Pharmaceuticals (ARNA)	United States	$2.200B	0.00
Acceleron Pharma (XLRN)	United States	$2.111B	0.00
Medicines (MDCO)	United States	$2.097B	0.00
UniQure (QURE)	Netherlands	$1.985B	0.00
Nabriva Therapeutics AG (NBRV)	Ireland	$1.979B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$1.947B	0.00
AnaptysBio (ANAB)	United States	$1.945B	0.00
MyoKardia (MYOK)	United States	$1.939B	0.00
NeoGenomics (NEO)	United States	$1.889B	153.69
REGENXBIO (RGNX)	United States	$1.845B	19.16
Zai Lab Unsponsored ADR (ZLAB)	China	$1.712B	0.00
Audentes Therapeutics (BOLD)	United States	$1.687B	0.00
Allakos (ALLK)	United States	$1.621B	0.00
Orchard Therapeutics Sponsored ADR (ORTX)	United Kingdom	$1.510B	0.00
Alector (ALEC)	United States	$1.474B	0.00
Atara Biotherapeutics (ATRA)	United States	$1.463B	0.00
Momenta Pharmaceuticals (MNTA)	United States	$1.423B	0.00
Lion Biotechnologies (IOVA)	United States	$1.365B	0.00
Innoviva (INVA)	United States	$1.358B	3.74
Myovant Sciences (MYOV)	United Kingdom	$1.355B	0.00
InflaRx (IFRX)	Germany	$1.331B	0.00
Cambrex (CBM)	United States	$1.329B	14.31
Puma Biotechnology (PBYI)	United States	$1.303B	0.00
Editas Medicine (EDIT)	United States	$1.292B	0.00
Rubius Therapeutics (RUBY)	United States	$1.274B	0.00
Aimmune Therapeutics (AIMT)	United States	$1.270B	0.00
Sangamo Therapeutics (SGMO)	United States	$1.204B	0.00
Apellis Pharmaceuticals (APLS)	United States	$1.202B	0.00
Epizyme (EPZM)	United States	$1.151B	0.00
Codexis (CDXS)	United States	$1.096B	0.00
Gossamer Bio (GOSS)	United States	$1.090B	0.00
Clovis Oncology (CLVS)	United States	$1.077B	0.00
Autolus Therapeutics Sponsored ADR (AUTL)	United Kingdom	$1.057B	0.00
Fate Therapeutics (FATE)	United States	$1.055B	0.00
NGM BIOPHARMACT (NGM)	United States	$1.017B	0.00
Coherus BioSciences (CHRS)	United States	$1.009B	0.00
Genfit SA (GNFT)	France	$0.950B	0.00
Dicerna Pharmaceuticals (DRNA)	United States	$0.945B	0.00
Deciphera Pharmaceuticals (DCPH)	United States	$0.924B	0.00
Eidos Therapeutics (EIDX)	United States	$0.905B	0.00
Inotek Pharmaceuticals (RCKT)	United States	$0.898B	0.00
RA PHARMCTL INC (RARX)	United States	$0.897B	0.00
Kiniksa Pharmaceuticals (KNSA)	Bermuda	$0.887B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$0.884B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.884B	35.72
WAVE Life Sciences (WVE)	Singapore	$0.881B	0.00
Alder BioPharmaceuticals (ALDR)	United States	$0.874B	0.00
Twist Bioscience (TWST)	United States	$0.850B	0.00
Cellectis (CLLS)	France	$0.847B	0.00
Y-mAbs Therapeutics (YMAB)	United States	$0.825B	0.00
Retrophin (RTRX)	United States	$0.824B	0.00
ANI Pharmaceuticals (ANIP)	United States	$0.815B	14.93
Intellia Therapeutics (NTLA)	United States	$0.739B	0.00
Arvinas (ARVN)	United States	$0.736B	0.00
Vericel (VCEL)	United States	$0.734B	0.00
Athenex (ATNX)	United States	$0.733B	0.00
Nightstar Therapeutics Sponsored ADR (NITE)	United Kingdom	$0.717B	0.00
Principia Biopharma (PRNB)	United States	$0.715B	0.00
Cara Therapeutics (CARA)	United States	$0.700B	0.00
Intra-Cellular Therapies (ITCI)	United States	$0.699B	0.00
G1 THERAPEUTICS (GTHX)	United States	$0.689B	0.00
ZIOPHARM Oncology Inc (ZIOP)	United States	$0.678B	0.00
Precision BioSciences (DTIL)	United States	$0.659B	0.00
Viking Therapeutics (VKTX)	United States	$0.628B	0.00
ObsEva SA (OBSV)	Switzerland	$0.620B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.602B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.598B	0.00
Revance Therapeutics (RVNC)	United States	$0.591B	0.00
Stemline Therapeutics (STML)	United States	$0.580B	0.00
Heska (HSKA)	United States	$0.578B	51.83
Kura Oncology (KURA)	United States	$0.564B	0.00
Zealand Pharma (ZEAL)	Denmark	$0.563B	6.27
Synthorx (THOR)	United States	$0.558B	0.00
Zymeworks (ZYME)	Canada	$0.529B	0.00
Acorda Therapeutics (ACOR)	United States	$0.520B	6.74
DBV Technologies (DBVT)	France	$0.516B	0.00
Mesoblast (MESO)	Australia	$0.513B	0.00
UROGEN PHARMA (URGN)	United States	$0.509B	0.00
Magenta Therapeutics (MGTA)	United States	$0.504B	0.00
Axsome Therapeutics (AXSM)	United States	$0.503B	0.00
Arcus Biosciences (RCUS)	United States	$0.485B	0.00
AVROBIO (AVRO)	United States	$0.472B	0.00
Cytokineticsorporated (CYTK)	United States	$0.469B	0.00
Krystal Biotech (KRYS)	United States	$0.467B	0.00
Sorrento Therapeutics (SRNE)	United States	$0.462B	0.00
Anika Therapeutics (ANIK)	United States	$0.453B	17.12
Scholar Rock Holding (SRRK)	United States	$0.448B	0.00
KALEIDO BIOSCI (KLDO)		$0.447B	0.00
PDL BioPharma (PDLI)	United States	$0.447B	9.97
ProQR Therapeutics (PRQR)	Netherlands	$0.441B	0.00
NuCana Sponsored ADR (NCNA)	United Kingdom	$0.440B	0.00
Replimune (REPL)	United States	$0.433B	0.00
Prothena (PRTA)	Ireland	$0.431B	0.00
CytomX Therapeutics (CTMX)	United States	$0.430B	0.00
Five Prime Therapeutics (FPRX)	United States	$0.427B	0.00
CYCLERION THERA (CYCN)	United States	$0.426B	0.00
Adaptimmune Therapeutics (ADAP)	United Kingdom	$0.426B	0.00
Gritstone Oncology (GRTS)	United States	$0.425B	0.00
Achillion Pharmaceuticals (ACHN)	United States	$0.424B	0.00
MediciNova (MNOV)	United States	$0.419B	0.00
Dynavax Technologies (DVAX)	United States	$0.407B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.406B	0.00
Senesco Technologies (ELOX)	United States	$0.405B	0.00
AMAG Pharmaceuticals (AMAG)	United States	$0.402B	0.00
STEALTH BIOTHER (MITO)	United States	$0.388B	0.00
Abeona Therapeutics (ABEO)	United States	$0.384B	0.00
Merus (MRUS)	Netherlands	$0.383B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.371B	0.00
Sinovac Biotech (SVA)	China	$0.371B	0.00
Albireo Pharma (ALBO)	United States	$0.369B	0.00
Kezar Life Sciences (KZR)	United States	$0.364B	0.00
Geron (GERN)	United States	$0.358B	0.00
UNITY Biotechnology (UBX)		$0.352B	0.00
Kindred Biosciences (KIN)	United States	$0.344B	0.00
Agenus (AGEN)	United States	$0.341B	0.00
PHASEBIO PHARMA (PHAS)	United States	$0.340B	0.00
BeyondSpring (BYSI)	United States	$0.339B	0.00
XBiotech (XBIT)	United States	$0.329B	0.00
BioDelivery Sciences (BDSI)	United States	$0.328B	0.00
AC Immune SA (ACIU)	Switzerland	$0.322B	0.00
Solid Biosciences (SLDB)	United States	$0.319B	0.00
Constellation Pharmaceuticals (CNST)	United States	$0.318B	0.00
Biofrontera AG Sponsored ADR (BFRA)	Germany	$0.315B	0.00
Cellular Biomedicine (CBMG)	United States	$0.307B	0.00
MannKind (MNKD)	United States	$0.299B	0.00
Kadmon Holdings (KDMN)	United States	$0.288B	0.00
Seres Therapeutics (MCRB)	United States	$0.284B	0.00
LogicBio Therapeutics (LOGC)	United States	$0.275B	0.00
Aduro Biotech (ADRO)	United States	$0.268B	0.00
Evelo Biosciences (EVLO)	United States	$0.266B	0.00
Kodiak Sciences (KOD)	United States	$0.264B	0.00
Kala Pharmaceuticals (KALA)	United States	$0.254B	0.00
Kamada (KMDA)	Israel	$0.251B	11.33
Enochian BioSciences (ENOB)	United States	$0.251B	0.00
Urovant Sciences (UROV)	United States	$0.250B	0.00
Novavax (NVAX)	United States	$0.248B	0.00
Cerecor (CERC)	United States	$0.245B	0.00
Strongbridge Biopharma (SBBP)	United States	$0.244B	0.00
Avid Bioservices (CDMO)	United States	$0.242B	0.00
Protagonist Therapeutics (PTGX)	United States	$0.240B	0.00
Syros Pharmaceuticals (SYRS)	United States	$0.233B	0.00
ResTORbio (TORC)	United States	$0.229B	0.00
Sutro Biopharma (STRO)	United States	$0.227B	0.00
Celyad SA (CYAD)	Belgium	$0.222B	0.00
ChromaDex (CDXC)	United States	$0.221B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$0.219B	0.00
Palatin Technologies (PTN)	United States	$0.217B	107.00
OSMOTICA PHARM (OSMT)	United States	$0.216B	0.00
Celcuity (CELC)	United States	$0.214B	0.00
OvaScience (MLND)	United States	$0.214B	0.00
ADMA Biologics Inc (ADMA)	United States	$0.212B	0.00
Eiger BioPharmaceuticals (EIGR)	United States	$0.211B	0.00
Spero Therapeutics (SPRO)	United States	$0.211B	0.00
Gamida Cell (GMDA)	Israel	$0.211B	0.00
Aeglea BioTherapeutics (AGLE)	United States	$0.211B	0.00
Intec Pharma (NTEC)	Israel	$0.210B	0.00
Athersys (ATHX)	United States	$0.210B	0.00
CorMedix Inc (CRMD)	United States	$0.209B	0.00
Cel-Sci (CVM)	United States	$0.203B	0.00
Axovant Sciences (AXGT)	United Kingdom	$0.201B	0.00
TOCAGEN INC (TOCA)	United States	$0.201B	0.00
Synlogic (SYBX)	United States	$0.200B	0.00
Mersana Therapeutics (MRSN)	United States	$0.200B	0.00
Arsanis (XFOR)	United States	$0.195B	0.00
VBI Vaccines (VBIV)	United States	$0.193B	0.00
Pfenex (PFNX)	United States	$0.182B	0.00
BioTime (BTX)	United States	$0.179B	0.00
Mustang Bio (MBIO)	United States	$0.178B	0.00
Arbutus Biopharma (ABUS)	Canada	$0.177B	0.00
Paratek Pharmaceuticals (PRTK)	United States	$0.176B	0.00
Compugen (CGEN)	Israel	$0.176B	0.00
Enzo Biochem (ENZ)	United States	$0.171B	0.00
Cue Biopharma (CUE)	United States	$0.170B	0.00
Menlo Therapeutics (MNLO)	United States	$0.166B	0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT)	United States	$0.164B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$0.159B	0.00
Verastem (VSTM)	United States	$0.158B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.155B	0.00
AVEO Pharmaceuticals (AVEO)	United States	$0.152B	0.00
Erytech Pharma SA Sponsored ADR (ERYP)	France	$0.147B	0.00
Chiasma (CHMA)	United States	$0.147B	0.00
Pieris Pharmaceuticals (PIRS)	United States	$0.144B	0.00
Trevena (TRVN)	United States	$0.138B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.134B	0.00
Anavex Life Sciences (AVXL)	United States	$0.132B	0.00
Liquidia Technologies (LQDA)	United States	$0.132B	0.00
Checkpoint Therapeutics (CKPT)	United States	$0.132B	0.00
Allena Pharmaceuticals (ALNA)	United States	$0.132B	0.00
Nymox Pharmaceutical (NYMX)	Canada	$0.130B	0.00
ASLAN Pharmaceuticals (ASLN)	Singapore	$0.127B	0.00
VolitionRX (VNRX)	Singapore	$0.127B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$0.123B	0.00
Aptinyx (APTX)	United States	$0.123B	0.00
Organovo Holdings (ONVO)	United States	$0.121B	0.00
Neothetics (EVFM)	United States	$0.119B	0.00
Provention Bio (PRVB)	United States	$0.117B	0.00
Brainstorm Cell Therapeutics (BCLI)	United States	$0.112B	0.00
Spring Bank Pharmaceuticals (SBPH)	United States	$0.110B	0.00
XOMA (XOMA)	United States	$0.108B	0.00
Unum Therapeutics (UMRX)	United States	$0.108B	0.00
Fortress Biotech (FBIO)	United States	$0.107B	0.00
INMUNE BIO INC (INMB)	United States	$0.105B	0.00
Catalyst Biosciences (CBIO)	United States	$0.104B	0.00
Moleculin Biotech (MBRX)	United States	$0.102B	0.00
Selecta Biosciences (SELB)	United States	$0.097B	0.00
Equillium (EQ)	United States	$0.096B	0.00
Catabasis Pharmaceuticals (CATB)	United States	$0.095B	0.00
Dyadic (DYAI)	United States	$0.095B	0.00
Cohbar (CWBR)	United States	$0.095B	0.00
NantKwest (NK)	United States	$0.087B	0.00
Signal Genetics (MGEN)	United States	$0.084B	0.00
Cocrystal Pharma (COCP)	United States	$0.083B	87.33
Verona Pharma American Depositary Share (VRNA)	United Kingdom	$0.083B	0.00
Merrimack Pharmaceuticals (MACK)	United States	$0.083B	0.00
Applied Genetic Technologies (AGTC)	United States	$0.081B	0.00
Alcobra (ARCT)	United States	$0.081B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.080B	0.00
SESEN BIO, INC (SESN)	United States	$0.080B	0.00
Sunesis Pharmaceuticals (SNSS)	United States	$0.079B	0.00
Aridis Pharmaceuticals (ARDS)	United States	$0.078B	0.00
Eyenovia (EYEN)	United States	$0.077B	0.00
Tiziana Life Sciences Sponsored ADR (TLSA)	United Kingdom	$0.077B	0.00
Aptose Biosciences (APTO)	Canada	$0.077B	0.00
Orgenesis (ORGS)	United States	$0.075B	0.00
ARAVIVE, INC (ARAV)	United States	$0.071B	0.00
OVID THERAPEUTC (OVID)	United States	$0.070B	0.00
Idera Pharmaceuticals (IDRA)	United States	$0.065B	0.00
AEterna Zentaris (AEZS)	United States	$0.065B	15.88
Alimera Sciences (ALIM)	United States	$0.065B	0.00
Cidara Therapeutics (CDTX)	United States	$0.065B	0.00
Sienna Biopharmaceuticals (SNNA)	United States	$0.064B	0.00
Vaccinex (VCNX)	United States	$0.063B	0.00
Zosano Pharma (ZSAN)	United States	$0.062B	0.00
Protalix BioTherapeutics (PLX)	Israel	$0.062B	0.00
Pluristem Therapeutics (PSTI)	Israel	$0.061B	0.00
VTv Therapeutics (VTVT)	United States	$0.061B	0.00
Proteostasis Therapeutics (PTI)	United States	$0.061B	0.00
NewLink Genetics (NLNK)	United States	$0.060B	0.00
Ophthotech (ISEE)	United States	$0.059B	0.00
Curis (CRIS)	United States	$0.058B	0.00
Apricus Biosciences (SEEL)	United States	$0.058B	0.00
ScPharmaceuticals (SCPH)	United States	$0.056B	0.00
Evogene (EVGN)	Israel	$0.056B	0.00
Prima BioMed (IMMP)	Australia	$0.052B	0.00
HOTH THERAPEUTC (HOTH)	United States	$0.052B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.051B	0.00
AquaBounty Technologies (AQB)	United States	$0.050B	0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT)	United States	$0.050B	0.00
Entera Bio (ENTX)	Israel	$0.049B	0.00
AZURRX BIOPHARM (AZRX)	United States	$0.048B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.047B	0.00
Vascular Biogenics (VBLT)	Israel	$0.047B	0.00
Celsion (CLSN)	United States	$0.046B	0.00
Clearside Biomedical (CLSD)	United States	$0.045B	0.00
Celldex Therapeutics (CLDX)	United States	$0.045B	0.00
Bellerophon Therapeutics (BLPH)	United States	$0.045B	0.00
Bionano Genomics (BNGO)	United States	$0.044B	0.00
ANCHIANO THERAP (ANCN)	Israel	$0.043B	0.00
BiondVax Pharmaceuticals (BVXV)	Israel	$0.041B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.041B	0.00
Aerpio Pharmaceuticals (ARPO)	United States	$0.040B	0.00
VIVUS (VVUS)	United States	$0.037B	0.00
OncoSec Medical (ONCS)	United States	$0.036B	0.00
Leap Therapeutics (LPTX)	United States	$0.036B	0.00
OncoMed Pharmaceuticals (OMED)	United States	$0.034B	0.00
Aptevo Therapeutics (APVO)	United States	$0.034B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.033B	0.00
Motif Bio Plc (MTFB)	United States	$0.032B	0.00
Caladrius Biosciences (CLBS)	United States	$0.030B	0.00
Sophiris Bio (SPHS)	United States	$0.029B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.027B	0.00
GTx (GTXI)	United States	$0.027B	0.00
GENPREX INC (GNPX)	United States	$0.027B	0.00
Novelion Therapeutics (NVLN)	Canada	$0.025B	0.00
Vical (VICL)	United States	$0.025B	0.00
Aileron Therapeutics (ALRN)	United States	$0.025B	0.00
Rexahn Pharmaceuticals (RNN)	United States	$0.025B	0.00
Aytu Bioscience (AYTU)	United States	$0.023B	0.00
Titan Pharmaceuticals (TTNP)	United States	$0.023B	0.00
Oragenics (OGEN)	United States	$0.022B	0.00
Galena Biopharma (SLS)	United States	$0.022B	0.00
ATyr Pharma (LIFE)	United States	$0.021B	0.00
TRACON Pharmaceuticals (TCON)	United States	$0.020B	0.00
Fibrocell Science Inc (FCSC)	United States	$0.020B	0.00
Benitec Biopharma (BNTC)	Australia	$0.019B	0.00
Advaxis (ADXS)	United States	$0.019B	0.00
IMMURON LTD (IMRN)	Australia	$0.019B	0.00
Gemphire Therapeutics (GEMP)	United States	$0.019B	0.00
CytRx (CYTR)	United States	$0.019B	0.00
Oncobiologics (OTLK)	United States	$0.019B	0.00
Histogenics (HSGX)	United States	$0.017B	0.00
Cleveland BioLabs (CBLI)	United States	$0.016B	0.00
TrovaGene (TROV)	United States	$0.016B	0.00
IBio (IBIO)	United States	$0.016B	0.00
Novogen (KZIA)	Australia	$0.016B	0.00
Prana Biotechnology (ATHE)	Australia	$0.016B	0.00
Vital Therapies (IMUX)	United States	$0.015B	0.00
BioPharmX (BPMX)	United States	$0.015B	0.00
Alliqua BioMedical (ALQA)	United States	$0.015B	0.00
Genetic Technologies (GENE)	Australia	$0.013B	0.00
MYOS RENS Technology (MYOS)	United States	$0.013B	0.00
Cyclacel Pharmaceuticals (CYCC)	United States	$0.012B	0.00
Dare Bioscience (DARE)	United States	$0.012B	0.00
Therapix Biosciences (TRPX)	Israel	$0.012B	5.89
Soligenix (SNGX)	United States	$0.012B	0.00
Neuralstem (CUR)	United States	$0.011B	0.00
RestorGenex (DFFN)	United States	$0.010B	0.00
AmpliPhi Biosciences (APHB)	United States	$0.010B	0.00
Flex Pharma (FLKS)	United States	$0.010B	0.00
Tenax Therapeutics (TENX)	United States	$0.010B	0.00
Hemispherx BioPharma (HEB)	United States	$0.009B	0.00
Pulmatrix (PULM)	United States	$0.009B	0.00
Synthetic Biologics (SYN)	United States	$0.009B	0.00
Proteon Therapeutics (PRTO)	United States	$0.009B	0.00
Edge Therapeutics (PDSB)	United States	$0.009B	0.00
ARCA Biopharma (ABIO)	United States	$0.006B	0.00
Stellar Biotechnologies (SBOT)	United States	$0.005B	0.00
Cytori Therapeutics Inc (CYTX)	United States	$0.005B	0.00
Cellect Biotechnology (APOP)	Israel	$0.005B	0.00
ContraVir Pharmaceuticals Inc (CTRV)	United States	$0.004B	0.00